Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-10

Clinical Trial Update: A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness of ezetimibe/atorvastatin 10 mg/40 mg combination versus separate ezetimibe 10 mg and atorvastatin 40 mg in partici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ezetimibe/atorvastatin 10 mg/40 mg combination tablet (ezetimibe/atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2013-07-10